Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. (THRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · THRX · as of Jun 9, 2026
Key Statistics
Explore Theseus Pharmaceuticals, Inc. Data
thrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 66.7%
Competitors & Peers
thrx competitorsTHRX
ATYR
CRGX
FSTX
LENZ
LSBStock Performance
Full HistoryAbout Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound,…
what is theseus pharmaceuticals, inc. · thrx stock overview · theseus pharmaceuticals, inc. company profile · who is theseus pharmaceuticals, inc. ceo · thrx NASDAQ · theseus pharmaceuticals, inc. headquarters · theseus pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Theseus Pharmaceuticals, Inc. (THRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 7, 2021. As of the latest trading session, THRX stock price is $4.07, with a market capitalization of $181.5M. The stock has returned -47.95% over the past 12 months and +1.63% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Theseus Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Theseus Pharmaceuticals, Inc. reported revenue of — and net income of -$47.1M. For detailed data — including Theseus Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Theseus Pharmaceuticals, Inc. (THRX) stock price is $4.07. The stock is traded on NASDAQ under the ticker symbol THRX. The 52-week range is $2.05 – $12.37.